Leave Your Message

Sustainable Endotoxin Testing in China: rCR Chromogenic Assay from Reliable Suppliers and Factory Solutions

,
Introducing rCR (Recombinant Cascade Reagents), the next-generation, animal-free solution designed for Bacterial Endotoxin Testing (BET). Sourced from leading Suppliers in China, our innovative rCR combines recombinant Factor C, Factor B, and pro-clotting enzyme to effectively replicate the LAL enzymatic cascade while removing interference from Factor G and (1→3)-β-D-glucan. In our chromogenic assays, endotoxin triggers a sequence of Factor C → B → pro-clotting enzyme, producing a colorimetric signal that accurately reflects endotoxin levels, with exceptional sensitivity down to 0.001 EU/mL. Fully compliant with USP (2025), rCR seamlessly integrates into standard BET platforms without requiring any hardware modifications. Our Factory is committed to providing sustainable, high-performance, and globally reliable endotoxin detection solutions, ideal for pharmaceuticals, medical devices, and water testing applications.
,

    Products Features

    The Recombinant Cascade Reagent (RCR) represents a significant advancement in bacterial endotoxin testing, serving as a sustainable and highly specific recombinant alternative to traditional Limulus Amoebocyte Lysate (LAL). Its development aligns with modern ethical and regulatory expectations while maintaining robust analytical performance.

    Sustainable & Animal-Free

    By utilizing recombinant technology, RCR eliminates dependency on horseshoe crab blood, supporting conservation efforts and promoting animal welfare. The recombinant cascade—comprising recombinant Factor C, Factor B, and proclotting enzyme—mirrors the native LAL reaction mechanism.

    Enhanced Specificity

    Unlike native LAL reagents, RCR is not activated by (1→3)-β-D-glucans, preventing false-positive results in complex pharmaceutical matrices. This significantly improves testing accuracy, supported by emerging pharmacopeial standards like the proposed USP <86>.

    Proven Performance

    RCR has demonstrated excellent sample compatibility across a range of real-world pharmaceutical products, yielding highly comparable results to traditional LAL-based methods and positioning it as a modern, responsible industry choice.

    Frequently Asked Questions

    What is Recombinant Cascade Reagent (RCR)?
    RCR is a highly specific recombinant alternative to traditional Limulus Amoebocyte Lysate (LAL), designed as a sustainable solution for bacterial endotoxin testing in the pharmaceutical industry.
    How does RCR support animal welfare?
    RCR is produced entirely through recombinant technology, eliminating the reliance on horseshoe crab blood. This supports global conservation efforts and ensures a stable reagent supply.
    Does RCR match the reaction mechanism of traditional LAL?
    Yes. The recombinant cascade in RCR—consisting of recombinant Factor C, Factor B, and proclotting enzyme—closely mirrors the native LAL reaction mechanism, ensuring highly correlated results.
    How does RCR prevent false-positive results?
    Unlike native LAL, RCR is not activated by (1→3)-β-D-glucans. This enhanced specificity eliminates false positives, improving test accuracy for complex pharmaceutical samples.
    Is RCR recognized by regulatory pharmacopeial standards?
    Yes, RCR adoption in regulated laboratory environments is facilitated by emerging standards, such as the proposed USP <86> chapter for bacterial endotoxins testing using recombinant reagents.
    Can RCR be used for real-world pharmaceutical products?
    Absolutely. RCR has demonstrated excellent sample compatibility and analytical performance across a wide range of real-world pharmaceutical products, matching the efficacy of traditional LAL.